Jane Street Group, LLC Vista Gen Therapeutics, Inc. Transaction History

Jane Street Group, LLC

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	BUY	$0.14 - $1.07 $9,541 - $72,926	68,156 New	68,156 $10,000
Q2 2022 Aug 16, 2022	SELL	$0.88 - $1.73 $51,472 - $101,189	-58,491 Closed	0 $0
Q1 2022 May 17, 2022	BUY	$1.14 - $2.09 $66,679 - $122,246	58,491 New	58,491 $73,000
Q3 2021 Nov 16, 2021	SELL	$2.62 - $3.45 $433,989 - $571,475	-165,645 Closed	0 $0
Q2 2021 Aug 16, 2021	BUY	$1.96 - $3.15 $285,611 - $459,018	145,720 Added 731.34%	165,645 $521,000

Q1 2021 May 18, 2021	BUY	$1.89 - $2.96 $37,658 - $58,978	19,925 New	19,925 $42,000
Q3 2020 Nov 17, 2020	SELL	$0.48 - $1.03 $35,021 - $75,149	-72,961 Closed	0 $0
Q2 2020 Aug 17, 2020	BUY	$0.37 - $0.61 $26,995 - $44,506	72,961 New	72,961 $38,000
Q2 2019 Aug 15, 2019	SELL	$0.54 - $1.33 $12,064 - $29,713	-22,341 Closed	0 $0
Q1 2019 May 16, 2019	BUY	$1.1 - $1.76 $24,575 - $39,320	22,341 New	22,341 $29,000

2.7M

Ticker VTGN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 206,836,000
Market Cap $730M
Description
VistaGen Therapeutics, Inc., a clinical-stage biopharmaceutical company, engages in developing and commercializing various medicines with the potential to care for anxiety, depression, and other disorders of the central nervous system (CNS). The company's CNS pipeline includes PH94B, a rapid-onset neuroactive nasal spray, which is in Phase III d...

Get notified when there are updates to the investment portfolio of Jane Street Group, LLC, based on Form 13F filings with the SEC.

Stay updated on Jane Street Group, LLC with notifications on news.